Circulaire actuelle London Drugs - Valable à partir du 25.11 au 31.12 - Page n° 9

Les produits de cette circulaire

device smart android apple

Contour. DEXCGEN Monitoring System Ü CURE RE Download the FREE FR CONTOUR°DIABETES CEE app today. You can find out more about the new CONTOUR°NEXT GEN system online at ascensiadiabetes.ca or by calling 1-800-268-7200. ® TM see ascensiadiabetes.ca/tm-mc. Google Play and the Google Play logo are trademarks of Google LLC. Apple and the Apple logo are trademarks of Apple Inc. registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Compatible devices can be found at http://compatibility.contourone.com. © 2022 Ascensia Diabetes Care Canada Inc. Disclaimers: - Before use please see the CONTOUR°NEXT GEN user uide for full instructions. * On a compatible Android or iOS device. For a ull list of compatible devices, please visit compatibility.contourone.com. + Current regulation based on Health Canada recognized ISO 15197:2013 standard requires results within +15% range, specifically: 295% of results must fall within +0.83 mmol/L for blood glucose concentrations <5.55 mmol/L or within +15% for blood glucose concentrations 25.55 mmol/L. + The survey was conducted with CONTOUR°NEXT ONE and results for other meters may vary. References: 1. CONTOUR°NEXT GEN Blood Glucose Monitoring System User Guide, Rev. 09/20. 2. Richardson JM et al. Clinical Relevanéel of Reapplication of Blood Samples During Blood Glucose Testing. Poster presented at the 20th Annual Diabetes Technology Meeting (DTM); November 12-14, 2020. 3. Ascensia Diabetes Care. Data on file. Smartson online survey, Sweden 2017. 352 respondents: People with type 1 and type 2 diabetes, over 18 years old, who tested at least 4-7 times a day. Participants received free meter and tests strips. Survey funded by Ascensia Diabetes Care. 4. Fisher W et al. User Experience With the Information-Motivation-Behavioral Skills (IMB)-Based CONTOUR*NEXT ONE Smart Meter and App System. Poster presented at the 78th Scientific Session of the American Diabetes Association (ADA); June 22- 26, 2018; Orlando, Florida. ASCENSIA